FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for Newly Diagnosed AML By Ogkologos - June 3, 2026 110 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study ASTX727-07 Source RELATED ARTICLESMORE FROM AUTHOR Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism EMA Recommends Extension of Indications for Ponatinib Associated with a New Pharmaceutical Form and a New Strength Could Functional Precision Medicine Be the New Precision Oncology? MOST POPULAR FDA Approves Belzutifan for Advanced Renal Cell Carcinoma January 19, 2024 Reunión anual de la American Society of Clinical Oncology de 2022:... June 4, 2022 Sen. Amy Klobuchar Announces Breast Cancer Diagnosis, Urges Women Not to... September 10, 2021 FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction... November 17, 2023 Load more HOT NEWS Liquid Biopsy Detects Brain Cancer and Early-Stage Kidney Cancer When Caregiving Takes a Toll Alectinib Approved as an Adjuvant Treatment for Lung Cancer Disguising Cancer as an Infection Helps the Immune System Eliminate Tumors
